Human Recombinant IFN-alpha 2A, STEMCELL Technologies (CAT#: STEM-CT-0883-ZJF)

Interferon-alpha (IFN-α) is a type I interferon, produced by virus-infected cells, and is released as a soluble factor to initiate antiviral responses (Isaacs & Lindenmann). IFN-α2 is the most potent IFN-α used in fundamental research and in most clinical applications. The best-known IFN-α2 subvariants, 2A and 2B, differ by only one or two amino acids at positions 23 and/or 34 of the mature protein (von Gabain et al.). Type I IFNs exert potent antitumor activity by increasing the cytotoxic activity of NK and T cells, as well as by inhibiting the proliferation of cancer cells (Paul et al.). Additionally, it has been shown that proinflammatory IFN-α modulates the function of B cells in patients with systemic lupus erythematosus (Chang et al.), and pegylated forms of IFN-alpha 2A and 2B have implications in the treatment of hepatitis C (Foster et al.).

Subtype: Cytokines
Cell Type: B Cells, Cancer Cells and Cell Lines, NK Cells, T Cells
Species: Human
Area of Interest: Cancer, Immunology
Purity: ≥ 95%

Reliable Consistency: Guarantees uniformity and repeatability in various applications with endotoxin levels below 0.2 EU/μg.
Free of Animal Components: Completely devoid of any animal or human-derived elements.
Broad Selection: Offers a wide range of human, mouse, and rat cytokines available in multiple sizes.

Human Recombinant HGF, STEMCELL Technologies
Human Recombinant Heregulin-beta 1, STEMCELL Technologies
Human Recombinant IFN-alpha 2B, STEMCELL Technologies
Human Recombinant IFN-beta, STEMCELL Technologies